Dr. TANG Tao
Research Fellow (honorary)
(852) 3505 2580
Dr. TANG Tao got his PhD in Dept of. O&G of the Chinese University of Hong Kong in 2008. He worked as Research Assistant Professor from 2013 and his current research interests mainly focused on Cervical cancer, RNAi based therapy strategy in cancer and Postmenopausal osteoporosis.
Cervical cancer; RNAi based therapy strategy in cancer and Postmenopausal osteoporosis
Summary of research output:
- Total publication: 11
- H-index 6
|1||The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer
Chen J, Deng Y, Ao L, Song Y, Xu Y, Wang CC, Choy KW, Chung TKH, Du Q, Sui Y, Yang T, Yang J, Li H, Zou C, Tang T
Cancer Lett. 2019 Sep 24;460:75-85
|2||Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer
Dong PX, Xiong Y, Yu JH, Chen L, Tang T, Song Y, Hanley SJB, Yue JM, Watari H, Sakuragi N
Oncogene. 2018 Sep; 37(39): 5257-5268
|3||Linc-ROR Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Functioning as a Competing Endogenous RNA for miR-138 and miR-145
Feng L, Shi L, Lu YF, Wang B, Tang T, Fu WM, He W, Li G, Zhang JF
Mol Ther Nucleic Acids. 2018 Jun 1;11:345-353
|4||Bioinformatics and Microarray Analysis of miRNAs in Aged Female Mice Model Implied New Molecular Mechanisms for Impaired Fracture Healing.
He B, Zhang ZK, Liu J, He YX, Tang T, Li J, Guo BS, Lu AP, Zhang BT, Zhang G
Int J Mol Sci Aug 2016;17(8): E1260
|5||Local Administration of siRNA through Microneedle: Optimization, Bio-distribution, Tumor Suppression and Toxicity.
Tang T, Deng Y, Chen J, Zhao Y, Yue RF, Choy KW, Wang CC, Du Q, Xu Y, Han L, Chung TKH
Sci Rep Jul 2016;6 (30430): 1 – 8
|6||Maternal Somatic Mosaicism of FOXF1 Mutation Causes Recurrent Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins in Siblings.
Luk HM, Tang T, Choy KW, Tong TMF, Wong OK, Lo FM
Am J Med Genet Part A Jul 2016;170(7): 1942 – 1944
|7||Inter-molecular β-sheet Structure Facilitates Lung-targeting siRNA Delivery.
Zhou J, Li D, Wen H, Zheng S, Su C, Yi F, Wang J, Liang Z, Tang T, Zhou D, Zhang L, Liang D, Du Q
Sci Rep Mar 2016;6 (22731): 1 – 10
|8||Transdermal Delivery of siRNA through Microneedle Array.
Deng Y, Chen J, Zhao Yi, Yan X, Zhang L, Choy KW, Hu J, Sant HJ, Gale BK, Tang T
Sci Rep Feb 2016;6 (21422): 1 – 8
|9||Blockage of Src by Specific siRNA as a Novel Therapeutic Strategy to Prevent Destructive Repair in Steroid-Associated Osteonecrosis in Rabbits.
Zheng L, Cao H, Chen S, Tang T, Fu W, Huang L, Chow DHK, Wang Y, Griffith JF, He W, Zhou H, Zhao D, Zhang G, Wang X, Qin L
J Bone Miner Res 2015;30(11): 2044 - 2057
|10||Magnetite Nanostructured Porous Hollow Helical Microswimmers for Targeted Delivery.
Yan X, Zhou Q, Yu J, Xu T, Deng Y, Tang T, Feng Q, Bian L, Zhang Y, Ferreira A, Zhang L
Adv Funct Mater 2015;25(33): 5333 - 5342
|11||Nanocomposite-strengthened Dissolving Microneedles for Improved Transdermal Delivery to Human Skin.
Yan L, Raphael AP, Zhu X, Wang B, Chen W, Tang T, Deng Y, Sant HJ, Zhu G, Choy KW, Gale BK, Prow TW, Chen X
Adv Healthc Mater 2014;3(4): 555 - 564
|12||Therapeutic Potentials of Gene Silencing by RNA Interference: Principles, Challenges, and New Strategies.
Deng Y, Wang CC, Choy KW, Du Q, Chen J, Wang Q, Li L, Chung TKH, Tang T
Gene 2014;538: 217 - 227
|13||MicroRNA-182 Plays an Onco-miRNA Role in Cervical Cancer.
Tang T, Wong HK, Gu W, Yu MMY, To KF, Wang CC, Wong YF, Cheung TH, Chung TKH, Choy KW
Gynecol Oncol 2013;129(1): 199 - 208
|14||Authentication of nasopharyngeal carcinoma tumor lines.
Chan SYY, Choy KW, Tsao GSW, Tao Q, Tang T, Chung GTY, Lo KW
Int J Cancer 2008;122(9): 2169 - 2171